Significados de alpha interferon em inglês

Currently, alpha interferon is the only recognized therapy for chronic viral hepatitis.

Two multiinstitutional trials are now underway to compare its effectiveness v alpha interferon.

Maintenance therapy with alpha interferon did not appear to prolong remission duration or survival.

NB-UVB alone or plus alpha interferon achieves a clinical CR in most early-stage patients.

Methods: Two hundred and ninety-six patients were included in four controlled trials of alpha interferon.

And NB-UVB alone or plus alpha interferon achieved a clinical complete response (CR).

Dose reduction in the amount of the alpha interferon administered was determined by a preestablished protocol.

To enhance the T cell effect six doses of 5 million units alpha interferon were given subcutaneously.

Two patients were treated with alpha interferon.

No full responses to alpha interferon therapy.

Conclusions: Change in quantitative HCV-RNA titre measured by bDNA assay at 4 weeks predicts response to alpha interferon.

Finally, the sensitivity of these replicon variants to alpha interferon or ribavirin remained unchanged compared to that of the wild-type.

All patients had not responded (n=20) or relapsed (n=1) after a previous six month course of alpha interferon therapy.

Trivalent inactivated influenza vaccine was given intranasally to healthy adult volunteers alone or with 1 million units (Mu) or 10 Mu of alpha interferon.

Alpha interferon-exposed isolates were not interferon resistant.

Alpha interferon appears to have its greatest potential as part of early induction therapy or during remission maintenance.